首页> 外国专利> DIAGNOSIS OF CANCER BY DETECTING AUTO-ANTIBODIES AGAINST PAR1

DIAGNOSIS OF CANCER BY DETECTING AUTO-ANTIBODIES AGAINST PAR1

机译:通过检测针对PAR1的自身抗体对癌症进行诊断

摘要

The present invention relates to a method for diagnosis of a cancer, comprising the steps of (i) determining the level of antibodies against protease-activated receptor 1 (PAR1) in a sample from a subject to be diagnosed, (ii) comparing the determined level in the sample to a control level derived from subjects without ovarian cancer; wherein a decreased level in the sample from the subject to be diagnosed as compared to the control level is indicative for ovarian cancer in the subject. Furthermore the invention relates to differential diagnosis of cancer and the prediction of the response of a subject to be treated for cancer with a drug.
机译:本发明涉及一种诊断癌症的方法,包括以下步骤:(i)确定来自待诊断对象的样品中针对蛋白酶激活受体1(PAR1)的抗体的水平,(ii)比较所确定的样品中的蛋白水平达到无卵巢癌受试者的对照水平;其中来自待诊断对象的样品中与对照水平相比降低的水平指示该对象中的卵巢癌。此外,本发明涉及癌症的鉴别诊断和预测要用药物治疗的受试者的反应。

著录项

  • 公开/公告号EP3102947B1

    专利类型

  • 公开/公告日2018-11-14

    原文格式PDF

  • 申请/专利权人 CELLTREND GMBH;

    申请/专利号EP20150704251

  • 发明设计人 HEIDECKE HARALD;SCHULZE-FORSTER KAI;

    申请日2015-02-03

  • 分类号G01N33/564;G01N33/574;G01N33/74;

  • 国家 EP

  • 入库时间 2022-08-21 12:27:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号